Healthcare staff at no greater risk of dying from Covid-19 than the general population
Healthcare workers are at no greater risk of dying from coronavirus than the general public, new figures have revealed.
According to the Office for National...
No end to Covid-19 lockdown yet but ‘careful’ easing begins: Johnson
The coronavirus lockdown will not end yet, British prime minister Boris Johnson said on Sunday (10), urging people to "stay alert" to the risks...
UK warns no big changes to virus lockdown
The British government warned the public on Friday (8) not to expect any major changes to the nationwide coronavirus lockdown next week, as the...
UK Covid-19 toll passes 31,000
More than 31,000 people who have tested positive for coronavirus have now died in Britain, new health ministry figures showed on Friday (8).
The number...
No harm or benefit to Covid-19 patients from Hydroxychloroquine: Study
A study performed in New York hospitals found no evidence of either harm or benefit from giving the malaria drug hydroxychloroquine to severely ill...
RPS issues guidance on new CD regulations for pandemic supply
The Royal Pharmaceutical Society (RPS) has issued guidance for pharmacists on controlled drugs (CDs) regulations for pandemic supply.
Three changes to the Misuse of Drugs...
RPS urges to ensure safety of BAME healthcare workers
The Royal Pharmaceutical Society has urged the NHS and government to include pharmacy in national plans to keep BAME healthcare workers safe as they...
Britons applaud Covid-19 carers as Johnson prepares to ease lockdown
Britons joined in a weekly nationwide round of applause on Thursday (7) to pay tribute to care workers and hospital staff for the last...
MHRA’s Covid-19 medicines warning
The Medicines and Healthcare products Regulatory Agency (MHRA) has urged the public to remain cautious about the medicines and other medical products being sold...
All formulations of Ranitidine may remain out of stock Â
The Department of Health and Social Care (DHSC) has said in a supply notification that all formulations of Ranitidine are likely to remain out...
Current Issue March 2024
